Quarterly activity
Press
release Ecully,
16 April
2021 – 6
p.m.
Q1 2021
revenue
In accordance with Spineway’s forecasts, revenue
for the first quarter of 2021 followed the trend of year-end 2020
and amounted to €0.9M (€1M for Q1 2020) as a result of the new
public-health measures in place in the various countries in which
Spineway operates. As a reminder, revenue for the first quarter is
usually lower than that of other quarters due to the structure of
the Group’s markets. Also, this figure does not yet show the
effects of the Group’s various sales initiatives and developments
that should bear fruit in the next two quarters.
Sales in Latin
America
remained steady despite being particularly hard-hit (especially
Brazil) by the pandemic and represented 49% of the Group’s revenue.
Asia represented 22% of the
Group’s revenue and, after a good Q4 2020, had a gradual uptick in
orders that should continue through the second quarter of 2021.
Europe posted a 33% increase in sales thanks to a
return to activity in France (+39%).
As announced, the Group should be receiving its
first orders in the United States1 during the second quarter and,
as soon as recovery from the pandemic begins, benefit from all
non-emergency surgeries being scheduled again in hospitals. In
addition, Spineway has a very solid cash position that allows it to
continue its development and pursue negotiations for the
acquisition of a European start-up2 specialized in the design,
manufacture and sale of implants and instruments for spinal
surgeries.
Upcoming:
2021 half-year revenue –
13 July
20213
SPINEWAY IS ELIGIBLE FOR
THE PEA-PME (EQUITY SAVINGS PLANS
FOR SMES)Find out all about Spineway at
www.spineway.com
This press release has been prepared in both
English and French. In case of discrepancies, the French version
shall prevail.
Spineway
designs, manufactures and
markets innovative implants and
surgical instruments for treating
severe disorders of the spinal
column.Spineway
has an international network of over 50
independent
distributors and
90% of its revenue comes from
exports.Spineway,
which is eligible for
investment through FCPIs (French
unit trusts specializing in innovation),
has received the OSEO Excellence
award since 2011 and has
won the Deloitte Fast 50
award (2011). Rhône Alpes INPI
Patent Innovation award (2013)
– INPI Talent award
(2015). ISIN:
FR0011398874 - ALSPW
Contacts:
SPINEWAYShareholder-services lineAvailable Tuesday
through Thursday(10 a.m. – 12 p.m.)+33 (0)811 045 555 |
Eligible PEA / PMEALSPWEuronext Growth |
AELIUM Finance & CommunicationInvestor
relationsSolène Kennisspineway@aelium.fr |
1 See press release dated 29 March 20212 See press release dated
18 March 20213 As current activity is not representative, and in
accordance with AMF regulations, Spineway has decided to stop
releasing quarterly revenue. From now on, it will only publish
half-year revenue, unless there is something significant to
report.
Spineway (EU:ALSPW)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Spineway (EU:ALSPW)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024